Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

42 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections: Viral and Bacterial

(P-659) Pilot Phase Results of the ARIA Study: Acute Respiratory Illness among Adults 50 and Older in the Outpatient Setting

Monday, October 20, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Co-Author(s)

JK

Jennifer L. Kuntz, MS, PhD

Investigator
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
Holly C. Groom, MPH

Research Associate
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
JM

Jennifer K. Meece, PhD

Director and Research Scientist
Marshfield Clinic Research Institute
Marshfield, Wisconsin, United States
JD

John F. Dickerson, PhD

Investigator
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
RM

Richard A. Mularski, MD, MSHS, MCR

1. Kaiser Permanente Center for Health Research, Portland, Oregon
Portland, Oregon, United States
WH

Weiming Hu, MS

Data Reporting and Analystics Consultant, Biostatistics
Kaiser Center for Health Research
Portlannd, Oregon, United States
MO

Maureen O'Keeffe-Rosetti, MS

Research Associate III
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
Nicola P. Klein, MD, PhD (she/her/hers)

Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
KJ

Karen Jacobson, MD, MPH

Kaiser Permanente Vaccine Study Center, Division of Research
Oakland, California, United States
AW

Amy Wiesner, RN, BSN

Kaiser Permanente Vaccine Study Center, Division of Research
Oakland, California, United States
CO

Courtney Oxandale, RN, BSN

Kaiser Permanente Vaccine Study Center, Division of Research
Oakland, California, United States
Lisa Glasser, MD (she/her/hers)

Head US Medical Affairs Vaccines and Immune Therapies
AstraZeneca
Wilmington, DE, United States
SV

Sudhir Venkatesan, MPH, PhD

Medical and Payer Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Cambridge, UK
Cambridge, England, United Kingdom
CT

Carla Talarico, PhD, MPH (she/her/hers)

Director
Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
Gaithersburg, Maryland, United States

Presenting Author(s)

MS

Mark A. Schmidt, PhD, MPH (he/him/his)

Senior Investigator
Center for Health Research, Kaiser Permanente Northwest
Portland, Oregon, United States